First Time Loading...

BioXcel Therapeutics Inc
NASDAQ:BTAI

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
NASDAQ:BTAI
Watchlist
Price: 1.415 USD -4.39% Market Closed
Updated: Jun 9, 2024

BioXcel Therapeutics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioXcel Therapeutics Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
BioXcel Therapeutics Inc
NASDAQ:BTAI
PP&E Gross
$1.3m
CAGR 3-Years
-24%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is BioXcel Therapeutics Inc's PP&E Gross?
PP&E Gross
1.3m USD

Based on the financial report for Mar 31, 2024, BioXcel Therapeutics Inc's PP&E Gross amounts to 1.3m USD.

What is BioXcel Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
-10%

Over the last year, the PP&E Gross growth was -31%. The average annual PP&E Gross growth rates for BioXcel Therapeutics Inc have been -24% over the past three years , -10% over the past five years .